Development of a zero-order sustained-release tablet containing mesalazine and budesonide intended to treat the distal gastrointestinal tract in inflammatory bowel disease-Reference-Cited by-同舟云学术

Development of a zero-order sustained-release tablet containing mesalazine and budesonide intended to treat the distal gastrointestinal tract in inflammatory bowel disease

Published:2016-06 Issue: Volume:103 Page:32-42
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Gareb Bahez,Eissens Anko C.,Kosterink Jos G.W.,Frijlink Hendrik W.

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference70 articles.

1. Inflammatory bowel disease;Abraham;New Engl. J. Med.,2009

2. Inflammatory bowel disease: clinical aspects and established and evolving therapies;Baumgart;Lancet,2007

3. Colonoscopic evaluation in ulcerative colitis;Paine;Gastroenterol. Rep. (Oxf),2014

4. European evidence-based Consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis;Stange;J. Crohns Colitis,2008

5. The second European evidence-based consensus on the diagnosis and management of crohn’s disease: definitions and diagnosis;Van Assche;J. Crohns Colitis,2010

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents;Saudi Journal of Gastroenterology;2024-08-30

2. Formulation and optimization of a single-layer coat for targeting budesonide pellets to the descending Colon;Pharmaceutical Development and Technology;2024-03-06

3. Colon-targeted delivery systems of budesonide as second-line therapy in inflammatory bowel disease;Journal of Drug Delivery Science and Technology;2024-03

4. Combination of time-dependent polymer and inulin as a coating for sustained delivery of budesonide pellets aimed for use in IBD treatment;Journal of Drug Delivery Science and Technology;2023-10

5. Capsules with Ileocolonic-Targeted Release of Vitamin B2, B3, and C (ColoVit) Intended for Optimization of Gut Health: Development and Validation of the Production Process;Pharmaceutics;2023-04-28